ARCHIVES

OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes

This article is from The Cancer Letter archive.

Vol. 11 No. 35 | September 13, 1985

Download PDF Visit The Full Archive

Related Articles

Risk Assessment Key In Long-Term Treatment

August 29, 2008

NCI Plans Program To Help Academics With Initial Stages of Drug Discovery.

November 30, 2007

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive

November 27, 1987

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

In Brief: Oliverio Moves to DEA; Kushner Blass NIH Slow Pay; DeVita Welcomes Hawkin’s Probe

February 6, 1981